Cite
APA Citation
El-Khoueiry, A., Gitlitz, B., Cole, S., Tsao-Wei, D., Goldkorn, A., Quinn, D., Lenz, H., Nieva, J., Dorff, T., Oswald, M., Berg, J., Menendez, X., Karakozian, K., Krasnoperov, V., Liu, R., Thomas, J., Groshen, S., & Gill, P. (n.d.). a first-in-human phase I study of sEphB4-HSA in patients with advanced solid tumors with expansion at the maximum tolerated dose (MTD) or recommended phase II dose (RP2D). European journal of cancer, 69, S11–. http://access.bl.uk/ark:/81055/vdc_100039473315.0x000004